NewLink Genetics Announces Presentation of Abstracts at ASCO 2018 Annual Meeting

NEXT STORY
PRA Health Sciences, Inc. Reports First Quarter 2018 Results
PREV STORY
Portola Pharmaceuticals to Present New Interim Phase 2 Data for Cerdulatinib at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

GeoVax Presenting at Upcoming Scientific Conferences

Plug & Play Platform Continues to be Recognized for Distinct Benefits ATLANTA, GA, Nov. ...

author_avatar
NASDAQ Market News

Drug Master File for Prostate Imaging Product Filed with the FDA

MELBOURNE, Australia and INDIANAPOLIS, March 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) ...

author_avatar
NASDAQ Market News

TESARO Announces Closing of $155 Million Private Placement

WALTHAM, Mass., March 18, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

author_avatar
NASDAQ Market News